Patents by Inventor Michael Raymond Harnden

Michael Raymond Harnden has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6579981
    Abstract: A compound of formula (I) or a salt or acyl derivative thereof, in which X represents chlorine, C1-6 alkoxy, phenoxy, phenyl C1-6 alkoxy, NH2, —OH or —SH, is useful in treating viral infections.
    Type: Grant
    Filed: September 23, 1994
    Date of Patent: June 17, 2003
    Assignee: Novartis International Pharmaceutical Ltd.
    Inventors: Richard Lewis Jarvest, Michael Raymond Harnden
  • Patent number: 6573378
    Abstract: A compound of formula (I) or a salt or acyl derivative thereof, in which X represents chlorine, C1-6 alkoxy, phenoxy, phenyl C1-6 alkoxy, NH2, —OH or —SH, is useful in treating viral infections.
    Type: Grant
    Filed: December 15, 1994
    Date of Patent: June 3, 2003
    Assignee: Novartis International Pharmaceutical Ltd.
    Inventors: Richard Lewis Jarvest, Michael Raymond Harnden
  • Patent number: 4049816
    Abstract: Thiazolinone analogues of indolmycin having anti-viral activity as well as a degree of antibacterial and antimycoplasmal activity in contrast to the known indolmycin which has only some antibacterial activity. Tautomers and a single enantiomer or mixture of enantiomers are included. Intermediates are described which are cyclized to produce the active antiviral substances. Suitable dosage forms and amounts are set forth and various routes of administration included including administration to the respiratory tract as by insufflation or inhalation.
    Type: Grant
    Filed: March 15, 1976
    Date of Patent: September 20, 1977
    Assignee: Beecham Group Limited
    Inventors: Michael Raymond Harnden, Nicholas David Wright
  • Patent number: 3931198
    Abstract: A novel series of 2-amino-5-spiro substituted oxazolin-4-ones and intermediates for making said compounds. These compounds are prepared by first converting the appropriately substituted cycloketone to the corresponding cyclocyanohydrin; converting this compounds to the corresponding hydroxy acid; esterifying the hydroxy acid, and finally cyclizing the hydroester to form the 2-amino-5-spiro substituted oxazolin-4-one. These compounds exhibit central nervous system activity and are active as either stimulants or depressants, and some are useful as performance enhancers.
    Type: Grant
    Filed: February 20, 1973
    Date of Patent: January 6, 1976
    Assignee: Abbott Laboratories
    Inventor: Michael Raymond Harnden
  • Patent number: 3931397
    Abstract: This invention relates to antiviral substances, to a method for their preparation, and to pharmaceutical compositions comprising them.
    Type: Grant
    Filed: November 8, 1973
    Date of Patent: January 6, 1976
    Assignee: Beecham Group Limited
    Inventor: Michael Raymond Harnden